Setenay Sarioglu, A. Tufan, Y. Ozturk, Dilara Ozdemir
{"title":"Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder","authors":"Setenay Sarioglu, A. Tufan, Y. Ozturk, Dilara Ozdemir","doi":"10.5455/pbs.20221012042348","DOIUrl":null,"url":null,"abstract":"Oro-mandibular dystonia (OMD) involves repetitive uncontrollable contractions of the lower facial muscles. Its etiology is not fully elucidated although various neurological (encephalitis, etc.), psy-chogenic, and psychopharmacological (SSRIs, antipsychotics, etc.) causes were implicated. Ado-lescent patients developing OMD after treatment with sertraline or fluoxetine alone were reported previously. In this case, we reported OMD in a patient with sequential trials of different SSRIs. Despite its rarity, this adverse effect may be borne in mind by clinicians.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedPress psychiatry and behavioral sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/pbs.20221012042348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Oro-mandibular dystonia (OMD) involves repetitive uncontrollable contractions of the lower facial muscles. Its etiology is not fully elucidated although various neurological (encephalitis, etc.), psy-chogenic, and psychopharmacological (SSRIs, antipsychotics, etc.) causes were implicated. Ado-lescent patients developing OMD after treatment with sertraline or fluoxetine alone were reported previously. In this case, we reported OMD in a patient with sequential trials of different SSRIs. Despite its rarity, this adverse effect may be borne in mind by clinicians.